With more than 20 years of experience in the biopharmaceutical industry, Dr. Schneider is responsible for the worldwide administrative functions at PAREXEL including Corporate Services, Information Technology, Human Resources, Facilities, Purchasing, and Regional Management. Read More

Ulf Schneider, Ph.D.
Senior Vice President and Chief Administrative Officer

Gadi Saarony, Senior Vice President, Clinical Research Services (CRS), is responsible for Phase II-III clinical research services, including clinical operations, project management and resourcing, in more than 50 countries. He also oversees the business process excellence team, which is dedicated to improving processes across the Company. In addition, Mr. Saarony works closely with PAREXEL’s Strategic Partnerships and key accounts. He is a member of the Business Review Committee (BRC), the Company’s most senior leadership team. Read More

Gadi Saarony
Senior Vice President, Clinical Research Services

Xavier Flinois is President of Perceptive Informatics, PAREXEL’s technology subsidiary. He is also a member of PAREXEL’s Business Review Committee (BRC), the Company’s most senior leadership group. Xavier joins the company with more than 20 years of experience in the technology and healthcare services sector. Read More

Xavier Flinois
President, Perceptive Informatics

As Senior Vice President of Clinical Research Services, Dr. Cooper’s role includes general management and responsibility for PAREXEL’s Global Research Operations. Dr. Cooper oversees PAREXEL’s worldwide clinical and data management operations as well as patient recruitment, promoting dedication to the highest quality standards. Read More

Anita Cooper, MA, D.Phil
Senior Vice President

Mr. Batt is Senior Vice President and General Counsel, as well as Secretary of the Corporation. In this capacity, Mr. Batt oversees the Company's worldwide corporate legal responsibilities as well as corporate governance matters. Read More

Douglas A. Batt
Senior Vice President and General Counsel

Ingo Bank is Senior Vice President, Chief Financial Officer and a member of the Business Review Committee (BRC), the Company’s most senior leadership team. Read More

Ingo Bank
Senior Vice President, Chief Financial Officer

In his role as President and Chief Operating Officer (COO), Dr. Goldberg leads PAREXEL’s global management team to capitalize on the strong market opportunity for global biopharmaceutical services. Read More

Mark A. Goldberg, M.D.
President and Chief Operating Officer

As Chairman and CEO of PAREXEL, Mr. von Rickenbach has taken PAREXEL from its pioneering beginnings as one of the first clinical research organizations (CROs) three decades ago to its place as one of the top public biopharmaceutical services companies today. Read More

Josef H. von Rickenbach
Chairman of the Board and Chief Executive Officer